Identification of Novel FZD4 Mutations in Familial Exudative Vitreoretinopathy and Investigating the Pathogenic

Erkuan Dai1, Min Liu2,3, Shujin Li2,3

  • 1Department of Ophthalmology, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Abstract

Insights

Five novel FZD4 mutations were identified in familial exudative vitreoretinopathy (FEVR). These FZD4 mutations compromise Norrin/β-catenin activation, and missense mutations can be categorized by functional changes.

Area of Science:

  • Genetics and Molecular Biology
  • Ophthalmology

Background:

  • Familial exudative vitreoretinopathy (FEVR) is a genetic disorder affecting retinal vasculature.
  • Mutations in the FZD4 gene are a known cause of FEVR, impacting the Norrin signaling pathway.

Purpose of the Study:

  • To identify and characterize novel FZD4 mutations in FEVR patients.
  • To analyze the functional impact of previously reported and newly discovered FZD4 missense mutations.

Main Methods:

  • Enrolled FEVR patients and family members for ocular examinations and genetic sequencing.
  • Constructed plasmids with FZD4 mutations for in vitro functional assays.
  • Assessed protein expression, Norrin/β-catenin activation, membrane localization, norrin binding, and DVL2 recruitment.

Main Results:

  • Identified five novel FZD4 mutations (S91F, V103E, C145S, E160K, C377F) associated with FEVR.
  • Demonstrated that these novel mutations impair FZD4's Norrin/β-catenin activation.
  • Classified 34 reported missense mutations into five categories based on functional disruption (signal peptide, cysteine, extracellular, transmembrane, intracellular domains).

Conclusions:

  • Expanded the known spectrum of FZD4 mutations causing FEVR.
  • Provided experimental evidence for classifying FZD4 missense mutations based on their distinct functional consequences.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...